MediPress Health (Israel) Performance
| MPRS Stock | 81.40 0.80 0.97% |
MediPress Health has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning MediPress Health are expected to decrease at a much lower rate. During the bear market, MediPress Health is likely to outperform the market. MediPress Health Lim right now secures a risk of 2.14%. Please verify MediPress Health Limited Partnership coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to decide if MediPress Health Limited Partnership will be following its current price movements.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediPress Health Limited Partnership are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MediPress Health may actually be approaching a critical reversion point that can send shares even higher in January 2025. ...more
MediPress |
MediPress Health Relative Risk vs. Return Landscape
If you would invest 7,530 in MediPress Health Limited Partnership on September 14, 2024 and sell it today you would earn a total of 610.00 from holding MediPress Health Limited Partnership or generate 8.1% return on investment over 90 days. MediPress Health Limited Partnership is generating 0.1916% of daily returns and assumes 2.1436% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than MediPress, and 97% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MediPress Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MediPress Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MediPress Health Limited Partnership, and traders can use it to determine the average amount a MediPress Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0894
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MPRS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.14 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average MediPress Health is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MediPress Health by adding it to a well-diversified portfolio.
MediPress Health Fundamentals Growth
MediPress Stock prices reflect investors' perceptions of the future prospects and financial health of MediPress Health, and MediPress Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MediPress Stock performance.
About MediPress Health Performance
By analyzing MediPress Health's fundamental ratios, stakeholders can gain valuable insights into MediPress Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MediPress Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MediPress Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about MediPress Health Lim performance evaluation
Checking the ongoing alerts about MediPress Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MediPress Health Lim help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 28.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing MediPress Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MediPress Health's stock is overvalued or undervalued compared to its peers.
- Examining MediPress Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MediPress Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MediPress Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MediPress Health's stock. These opinions can provide insight into MediPress Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MediPress Stock analysis
When running MediPress Health's price analysis, check to measure MediPress Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediPress Health is operating at the current time. Most of MediPress Health's value examination focuses on studying past and present price action to predict the probability of MediPress Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediPress Health's price. Additionally, you may evaluate how the addition of MediPress Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |